OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
35
Results
Show all
Save search
Copy query
Show results for
Unknown
(35)
Release Date
2022
(7)
2024
(6)
2023
(6)
2021
(4)
2025
(2)
2013
(2)
2011
(2)
2010
(2)
2020
(1)
2019
(1)
2016
(1)
2008
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636
|
biostudies-literature
Cite
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Not available
S-EPMC2911350
|
biostudies-literature
Cite
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Not available
S-EPMC4162127
|
biostudies-literature
Cite
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Not available
S-EPMC2937272
|
biostudies-literature
Cite
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort.
Not available
S-EPMC10151943
|
biostudies-literature
Cite
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.
Not available
S-EPMC9829320
|
biostudies-literature
Cite
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
Not available
S-EPMC9832916
|
biostudies-literature
Cite
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Not available
S-EPMC2748264
|
biostudies-literature
Cite
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Not available
S-EPMC6804613
|
biostudies-literature
Cite
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight.
Not available
S-EPMC7171946
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets